The European Peptide Society welcomes sponsorship or donations
Please contact members of the Executive Committee if you are interested in sponsorship opportunities.
The EPS would like to thank our sponsors…
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Continue reading →
Rapp Polymere manufactures a broad spectrum of high quality resins for solid phase synthesis (SPS) and a broad range of polyethylene glycol derivatives. Continue reading →
The PolyPeptide Group is a world leader in the industrial/commercial-scale manufacture of proprietary and generic GMP and non-GMP peptides. Continue reading →
Peptisyntha is at the leading edge of the latest innovation and development opportunities in the medical world. Peptisyntha conducts pioneering ventures based on the unique properties of peptides. Continue reading →
Lonza is a global leader in the production and support of active pharmaceutical ingredients, both chemically and biotechnologically, as well as in microbial control. Continue reading →
IRIS Biotech is specialized in reagents for peptide synthesis, PEGylation, Life Science research and biocatalysis. Continue reading →
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. Continue reading →
INTAVIS Bioanalytical Instruments AG is a leading company in developing, manufacturing and distributing systems to automate complex protocols in biochemistry and molecular biology. Continue reading →
BCN Peptides SA is completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. Continue reading →
The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.
A Two-Day Intensive Course with the Emphasis on Formulation and Dosage Form Design Strategies, Analytical Methods and Excipient Choices Course Background and Objectives To provide attendees with a solid understanding of the most common mechanisms of protein degradation; an overview of where pharmaceutical proteins are most likely to be damaged during bioprocessing and storage; the physical basis for the aggregation and solubility behaviour of polypeptides; descriptions of the most important analytical tools needed in formulation Continue reading →
The Peptide Engineering Meeting (PEM) is a triennial international symposium addressing themes relevant to chemists, biologists, and researchers active in the fields of peptide folding and materials science. In particular, concepts such as the structure based design of peptides, peptide-protein interactions, peptide-membrane interactions, bioactive peptides and peptide based materials are emphasized. It also serves as an excellent platform to foster international collaboration. Previous meetings in this series were held in Osaka (Japan, 1997), Naples (Italy, Continue reading →
On behalf of the organizing committee, we are happy to announce the 4th International Conference on Circular Proteins and Peptides (formerly the International Conference on Circular Proteins) to be held in Kawasaki, Japan. The conference will consists of three days of presentations on the latest research in circular proteins and peptides by experts from around the globe. We are excited to be the first country to host this conference series outside of Australia and hope Continue reading →